Tumor tissue modified viral (TTMV)-HPV DNA biomarker test predicts recurrence of HPV-driven oropharynx cancer after treatment
PHOENIX, February 24, 2022 — A large, multi-institutional study demonstrates that a blood test to detect circulating tumor DNA can ...